SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is trending due to its new collaboration with Novo Nordisk and the dismissal of their lawsuit, solidifying its position in the lucrative GLP-1 market. The community is actively discussing a short squeeze, fueled by high short interest and robust trading volume, as the stock demonstrates significant resilience even during broader market downturns.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending after reporting a strong Q4 earnings beat, achieving its first full year of GAAP profitability, and authorizing a $500 million stock buyback, fueling community debate between those anticipating a short squeeze and others concerned about modest growth guidance.

Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on April 27, 2001 and is headquartered in Norwest, Australia.

Incannex Healthcare Inc

Incannex Healthcare Limited - ADR

Incannex Healthcare (IXHL) is trending as it nears Nasdaq compliance day, fueling strong community anticipation for imminent End-of-Phase 2 (EOP2) results for its fast-tracked IHL-42X sleep apnea drug. Investors are aggressively discussing a potential short squeeze, buyout, or partnership, highlighting the stock's low float and market cap significantly below its cash on hand.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

Anticipation is exceptionally high for New Era Energy's imminent announcement of a major hyperscaler tenant for its Texas Critical Data Centers, with recent land acquisitions further highlighting its strategic position in providing integrated power for the booming AI data center sector. While many investors remain bullish on the potential for a significant short squeeze, community discussions reflect a mix of confidence and growing frustration over the timing of the awaited tenant news.

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.

Stryker Corp.

Stryker is in focus following a severe global cyberattack that has reportedly wiped internal data and halted operations, sparking community debate over the extent of business disruption, potential gains for cybersecurity firms, and whether the downturn presents a buying opportunity.

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

Abivax - ADR

Abivax is trending strongly amidst renewed acquisition speculation by major pharmaceutical companies, amplifying investor excitement around its obefazimod drug's potential as a blockbuster treatment for inflammatory bowel disease following positive clinical data. The community remains highly speculative on a significant buyout, driving active options trading despite recent company denials and upcoming scientific presentations.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is trending due to a significant upgrade from Morgan Stanley and a new strategic partnership with Perplexity, reinforcing its leadership in the cybersecurity sector amid increasing AI-driven threats and global tensions. The community is actively discussing its robust fundamentals and market positioning, though its premium valuation remains a point of conversation.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp (BULL) is trending amid widespread investor frustration over its persistent stock decline and ongoing share dilution, which many attribute to perceived mismanagement and lack of communication from the CEO. While some in the community highlight the company's user growth and revenue as signs of undervaluation, the prevailing sentiment discusses significant losses and the stock's consistent failure to rebound, making it a popular short target.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. It offers Alpha, Beta, Gamma, and orbital transfer vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 27, 2017 and is headquartered in Cedar Park, TX.

Firefly Aerospace Inc.

Firefly Aerospace is gaining significant attention following the successful Alpha Flight 7 mission, which successfully deployed a Lockheed Martin payload, and its recent inclusion in the substantial SHIELD "Golden Dome" defense contract, driving community optimism for its expanding role in the space and defense sectors.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the following segments: Advanced Technology Solutions (ATS), and Connectivity and Cloud Solutions (CCS). The Advanced Technology Solutions (ATS) segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The Connectivity and Cloud Solutions (CCS) segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica is experiencing significant volatility despite reporting robust Q4 earnings and raising future guidance, driven by accelerating AI data center demand and advancements in 1.6T networking programs. The community expresses frustration over seemingly irrational sell-offs and perceived manipulation, yet maintains strong conviction in the company's long-term growth as a critical AI infrastructure partner, even as some debate its valuation and substantial capital expenditure plans.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sierra Oncology is a late-stage biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer. The company harnesses its deep scientific expertise to identify compounds that target the root cause of disease. Sierra Oncology's team takes an evidence-based approach to understand the limitations of current treatments and explore new ways to change the cancer treatment paradigm. Sierra Oncology is transforming promise into patient impact.

SRRA
Sierra Oncology Inc

Feed

News

Sentiment

Fundamentals

Info

Latest SRRA News

SRRASierra Oncology Inc